New York Patent of the Month – July 2024
Aescape, Inc., a robotics company, is focused on bringing new solutions to the wellness industry. With the use of robotics, Escape plans to make massage and self-care a consistent and accessible experience.
During this mission, the company has developed new autonomous therapy technology – and secured a patent for their efforts. This system, driven by advanced sensor data and sophisticated control algorithms, revolutionizes the way soft body tissue is treated. Unlike traditional methods, which rely on manual adjustments and real-time control, Aescape’s invention integrates a predictive modeling approach.
At its core, the system receives real-time sensor data as the robotic manipulator moves along the body’s surface. This data includes ultrasound, depth imagery, and thermal readings, crucial for assessing tissue properties and deformations. Using this information, the system’s controller identifies anatomical layers and adjusts the motion plan accordingly. This adaptive capability ensures precise treatment tailored to individual anatomical variations.
One of the system’s standout features is its ability to modify the predefined motion plan based on tissue structural models. By incorporating finite element analysis (FEA), it predicts and adjusts for tissue deformations, even when visual sensors are obscured. This predictive capability is enhanced by machine learning, which refines motion plans based on past massage sessions, optimizing treatment outcomes over time.
Aescape’s invention addresses multiple treatment parameters simultaneously. It can target specific tissue layers with shear forces or maintain constant contact while moving along a structure. These capabilities are crucial for achieving therapeutic goals such as skin stimulation, muscle mobilization, or skeletal alignment—all while adapting in real-time to physiological changes like blood flow or muscle tension.
Aescape’s robotic massage system represents a paradigm shift in therapeutic robotics. By combining cutting-edge sensor technology with predictive modeling and adaptive control strategies, it sets a new standard for precision and effectiveness in autonomous therapy. This innovation not only enhances patient comfort and treatment outcomes but also opens doors to broader applications in medical and wellness contexts where precise, automated soft tissue manipulation is critical.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
